A sensitive and specific radioimmunoassay for plasma arginine vasopressin (AVP) has been used to study the effects of blood osmolality and volume in regulating AVP secretion in unanesthetized rats. Under basal conditions, plasma AVP and osmolality were relatively constant, averaging 2.3±0.9 (SD) pg/ml and 294±1.4 mosmol/kg, respectively. Fluid restriction, which increased osmolality and decreased volume, resulted in a progressive rise in plasma AVP to about 10 times basal levels after 96 h. A 2-3-fold increase in plasma AVP occurred as early as 12 h, when osmolality and volume had each changed by less than 2%. Intraperitoneal injections of hypertonic saline, which had no effect on blood volume, also produced a rise in plasma AVP that was linearly correlated with the rise in osmolality (r > 0.9) and quantitatively similar to that found during fluid restriction (plasma AVP increased 2-4-fold with each 1% increase in osmolality). Intraperitoneal injection of polyethylene glycol, which decreased blood volume without altering osmolality, also increased plasma AVP but this response followed an exponential pattern and did not become significant until volume had decreased by 8% or more. At these levels of hypovolemia, the osmoregulatory system continued to function but showed a lower threshold and increase sensitivity to osmotic stimulation. We conclude that AVP secretion is regulated principally by blood osmolality but that the responsiveness of this […] Research Article
INTRODUCTION Arginine vasopressin (AVP)
is a nonapeptide hormone of the posterior pituitary that causes antidiuresis in man and most other mammals. Although secretion of the hormone is known to be affected by changes in both blood osmolality and volume (1) , the relative importance of these two variables in physiologic control of AVP has not been well established. This has been due largely to the lack of a suitable method for accurately measuring blood AVP at the low concentrations normally present under basal conditions. The development in our laboratory of a sensitive and specific radioimmunoassay for plasma AVP prompted us to reinvestigate these control mechanisms. By using techniques that permitted small changes in either blood osmolality or volume to be made independently, we have been able to quantitate the relative effectiveness of these two variables in altering AVP secretion in unanesthetized rats. Our findings indicate that, under normal conditions, small changes in osmolality are more potent than small changes in blood volume in affecting AVP secretion. However, the responsiveness of the osmoreceptor mechanism appears to be significantly altered by modest changes in blood volume, indicating a close interrela-1 Abbreviations used in this paper: AVP, arginine vasopressin; BV, blood volume; Hct, hematocrit; PEG, polyethylene glycol; PAxP, plasma AVP; POSm, plasma osmolality.
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METHODS
Male Sprague-Dawley rats, 150-250 g body wt, were maintained on ad lib food and water intake at constant temperature and humidity for at least 72 h before use. Three techniques were used to produce changes in blood osmolality and/or volume: a) complete fluid restriction for periods of from 12 to 96 h; b) i.p. injection of distilled water, isotonic or hypertonic saline; and c) i.p. injection of a nonabsorbable polymer, polyethylene glyc<ol (Carbowax 4000, Union Carbide Corp., Los Angeles, Calif) dissolved at varying concentrations in hypotonic, isotonic, or hypertonic saline.
At appropriate intervals after these procedures, the rats were guillotined without anesthesia and the blood issuing from the vessels of the trunk collected in chilled heparinized tubes. Small aliquots were drawn immediately into capillary tubes for microhematocrit determinations, and the remainder centrifuged at 4VC. The plasma was carefully aspirated and an aliquot taken for determination of Effects of saline and distilled water injections. The i.p. injection of 2 ml/100 g body wt of hypertonic saline (1,000 mosmol/kg), resulted in a prompt and parallel rise in plasma osmolality and AVP, both of which peaked at 15 min and then declined at similar rates (Fig. 2) . The injection of the same amount of distilled water was followed by an equally prompt fall in mean plasma osmolality to 287 mosmol/kg and in mean plasma AVP concentration to the barely detect- able level of 0.5 pg/ml. The i.p. injection of isotonic saline did not significantly alter either plasma osmolality or AVP concentration.
The mean blood hematocrit in rats receiving hypertonic saline was about 1% lower than in the control rats. This change was not statistically significant for the relatively small number of samples involved in any one experiment, but analysis of pooled data from four such experiments (n = 36) revealed an overall fall in mean (+SD) blood hematocrit, from 37.7±1.0 to 36.5 ±+1.5%, that was significant (P < 0.05). The injection of isotonic saline had no appreciable effect on hematocrit.
When rats were injected i.p. with different concentrations of saline and sacrificed 30 min later, the resultant increase in plasma AVP was found to be directly proportional to the level of plasma osmolality achieved (Fig. 3) . At osmolalities above 292 mosmol/ kg, a precise, linear relationship (r = 0.95, P < 0.001) between plasma AVP (PAVP) and osmolality (Posim) was *observed that was described by the regression equation PAVP = 0.83Posm -242. This equation could be rearranged to the more useful form PAVP = 0.83 (Posm -292), in which 0.83 represents the slope of the regression line, and 292 its intercept on the osmolality or X-axis. Representative values from six other such experiments conducted over a 12 mo period are shown in Table I . In all cases, the correlation coefficients were greater than 0.9 and the intercept on the osmolality axis very close to 292 mosmol/kg. However, considerable variation in the slope of the regression line (0.8-1.9) was observed. This variability did not appear to follow a seasonal pattern nor to correlate with slight differences in the weight, diet, or housing arrangements of the animals.
Effects of polyethylene glycol (PEG) injections. The i.p. injection of isotonic saline containing PEG produced a rapid, progressive rise in hematocrit, without altering plasma osmolality (Fig. 4) . This increase in hematocrit, which reflected a fall in plasma volume, was significant by 30 min and continued to increase for at least 3 h. This was associated with a progressive rise in plasma AVP, but this rise was delayed and did not become significant until 1 h after the injection, by which time blood volume was calculated to have decreased by about 9%.
When isotonic saline containing various concentrations of PEG were injected and the rats sacrificed 2 h later, a dose-related rise in hematocrit and plasma AVP was observed. In those animals in whom plasma osmolality remained at or near control levels (294 mosmol/ kg), the increase in plasma AVP was related to the change in hematocrit, and hence blood volume, by a curvilinear function (Fig. 5 ). Significant increases in plasma AVP over control levels were observed only in those animals with an hematocrit greater than 39%, which corresponded to a fall in blood volume of about 7%. Beyond this point, PAVP rose at an increasing rate relative to the degree of hypovolemia present. This relationship was best described by an exponential equation, PAVP = 1.3eolAVO', in which PAVP represents the plasma AVP concentration and Avol the percent change in blood volume as calculated from the change in hematocrits. in association with variable changes ii lality (Fig. 6) saline containing Under basal conditions, plasma AVP was relatively or 250 mg/ml. constant, averaging 2.3±0.9 pg/ml. This value is well of isotonic saline above the sensitivity limit of our assay (0.5 pg/ml) fter the injection and, since it did not seem to be affected by variations hematocrit deter-' rd hematocrit for in laboratory environment nor by minor stresses such and 36.1±1.0%, as the pain of injection, probably represents the true r each animal in "basal" level. Nearly identical values are found in norction of its blood mally hydrated recumbent adult humans (2). As ex-(see sthMetpheods)t pected, fluid deprivation resulted in a very marked inthe control group crease in plasma AVP as well as plasma osmolality >led experimental and blood hematocrit (Fig. 1) . This increase in AVP were not signifi-was readily detectable after only 12 h of fluid deprivast). tion when plasma osmolality had increased by less than 2%, and blood volume, as estimated from the change g concentrations in hematocrit, had declined by a similar amount. These stant amount of results amply document the extraordinary responsive-, or hypertonic ness of AVP secretion to small changes in water ballood hematocrit ance, but do not clarify whether the hormone response n plasma osmo-was due to the associated changes in osmolality, volbetween plasma ume, or both. To resolve this question, it was necessary in these PEG-to employ other experimental approaches that perffered quantita-mitted each of the two variables to be manipulated olemic controls. independently. fficient to reduce
Fortunately for these purposes, we found that i.p. ated with a sig-injection of hypertonic saline consistently produced a e of the line re-dose-related rise in plasma osmolality without apprecilarger dose of ably altering total blood volume (Fig. 2) AVP secretion (vide infra). Thus, the changes, in plasma AVP which follow the injection of hypertonic saline, can be attributed almost exclusively to the changes in plasma osmolality. The validity of this conclusion is also supported by the close linear relationship between plasma AVP concentration and plasma osmolality after hypertonic saline injection (Fig. 3 , Table I ). In over a dozen such experiments conducted over a 12 mo period, the correlation coefficient for this relationship was never less than 0.9, a result which testifies to the precision of the osmoreceptor mechanisnms that govern AVP secretion. The constancy of this mechanism is shown by the point of intercept of the various regression lines on the X or osmolality axis (Table I) . This value, which represents the "threshold" for the osmotically mediated release of AVP, was remarkably constant from one group of rats to the next, averaging about 292 mosmol/kg. Thus, "basal" plasma osmolality, which was also quite constant at about 294 mosmol/kg, appears to be maintained, probably by the thirst mechanism, only slightly above the osmotic threshold for AVP release. The sensitivity of this osmoregulatory system is represented by the slope of the regression lines relating plasma AVP to osmolality (Fig. 3, Table I ). Although this parameter was less constant from experiment to experiment than the threshold values, a slope of less than 0.8 has been observed only once in normal rats. This means that an increase in plasma osmolality of only 1% (2.9 mosmol/kg) regularly resulted in a rise in plasma AVP of at least 2.4 pg/ml, a result that amply confirms Verney's original conclusion concerning the sensitivity of this osmoregulatory system (7) . The reason for the apparent variability in osmoreceptor sensitivity is unclear. It did not seem to follow a seasonal pattern nor to be influenced by variations in the housing arrangements for the animals (Table I) . Recent studies in our laboratory suggest that osmoreceptor sensitivity may be subject to some circadian variation but this factor alone cannot account for the differences observed here.
To evaluate the characteristics of the volume-related (±SD) (large volume depletion). The regression line relating plasma AVP and plasma osmolality in the control group differed significantly from that for both the small volume (t = 3.66; P < 0.001) and large volume (t-= 4.26; P < 0.001) depletions.
plasma volume, and hence blood volume, which can be easily quantified from the resultant rise in hematocrit. The degree of hypovolemia produced can be controlled by varying either the duration of the injection (Fig. 4) or the concentration of PEG employed (Fig. 5) , while the effect on plasma osmolality can be regulated by varying the concentration of saline in which the PEG is dissolved (Fig. 6 ). With this approach it has been possible to show that the effects of hypovolemia on AVP secretion differ qualitatively as well as quantitatively from those of hyperosmolarity. Unlike the prompt response seen after hypertonic saline injection (Fig. 1) (Fig. 4) . This lag in AVP rely tributed to the exponential nature of response curve that characterizes the ef volume depletion (Fig. 5) . Thus depletion. This conclusion is also supported by prelimi-NCREASE nary studies in man where it has been found that removal of up to 6% of blood volume by phlebotomy has no effect on plasma AVP (11) . 7AVOL
When compared on the basis of percent change from 0 basal levels, it is readily apparent that small changes in blood osmolality are much more effective than small * changes in volume in altering AVP secretion (Fig. 7) .
Due to the exponential nature of the hypovolemic re-* sponse, however, very large increases in plasma AVP * can be produced more readily by reducing volume than by raising osmolality. The present studies demonstrate * .0 that this is not necessarily synonymous with the pri-* i macy of volume in regulating AVP secretion, as previously has been suggested (12) . * Our studies also confirm and extend a previous ob-* servation that hypovolemia does not abolish the influence of osmolality on AVP secretion (10) . Instead, hypovolemia appears to modify osmoregulatory function in such a way as to promote increased AVP release in response to a given level of plasma osmolality (Fig. |F*F 6, Table II ). The mechanisms of this effect, which 15 20 manifest both a reduction in the threshold and an inkNGE crease in the slope of the osmoreceptor response, are WVP to percent unknown. The studies of Gauer and Henry (13) and olume. The data Share (14) indicate that the effects of large volume l unltderFi(sM) depletions on AVP secretion are mediated, at least in 1level of 294.4 part, by afferent nerves from pressure-sensitive ren blood volume ceptors in the heart and large arteries of the chest and basal hematocrit neck. However, recent reports on the effects of angio-;ents one animal. tensin on AVP secretion (15, 16) raise the possibility that a humoral mechanism might also be involved. It is ltively late, well conceivable that each of the two parameters of osmoto substantial receptor function-threshold and sensitivity-is responease can be at-sive to a different volume-sensitive system, one huf the stimulus-moral and the other nervous. fects of isotonic We conclude that in the usual physiologic situation, rolemia was not such as a short period of fluid deprivation, the major nless the fall in stimulus to AVP secretion must be the resultant rise e 2-fold rise in in blood osmolality, since the accompanying changes in hypovolemia is volume are usually not of sufficient magnitude to be ter studies, also effective. Thus, the 2% decline in blood volume ob-I phlebotomy to served in our rats after 12 h of fluid deprivation could leehan, Sinclair, not by itself have caused the observed rise in plasma ion in the blood AVP, whereas the 1.5% rise in osmolality could easily rise in plasma have had this effect. During longer periods of fluid son, Zehr, and deprivation, however, the progressive fall in blood volplasma antidi-ume probably plays a more important role in mainhe blood volume taining AVP secretion. Under these conditions, neuroir comparison is hypophyseal stores of AVP decline progressively to hese two studies less than one-third normal levels (17), a circumstance 'EG method for that should result in a corresponding fall in the amount ime changes in of AVP released in response to a given stimulus (18 The fact that a decrease in the plasma AVP-osmolality relationship was not observed after prolonged fluid restriction (the relationship was quite similar to that after hypertonic saline injection) indicates enhancement of the osmotically mediated AVP secretion by the accompanying hypovolemia. This booster effect thus serves to insure the secretion of AVP in amounts sufficient to maintain maximum antidiuresis during prolonged water deprivation despite profound depletion of pituitary stores of the hormone.
